{ "schemaVersion": "deck-intelligence.v1", "id": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "slug": "085543019d5934281487d90fc26e88a2", "title": "argenx SE | Results Presentation Deck | 15 slides", "subtitle": "argenx · 2023-07", "author": "argenx", "date": "2023-07-01 00:00:00", "pageCount": 15, "kind": "conference-presentation", "orientation": "landscape", "aspectRatio": 1.7777778, "document": { "id": "019de075-3e55-76ad-a6bd-1aa5a42e575f", "slug": "085543019d5934281487d90fc26e88a2", "title": "argenx SE | Results Presentation Deck | 15 slides", "rawTitle": "argenx SE | Results Presentation Deck | 15 slides", "authorId": "argenx-se", "authorName": "argenx", "authorDisplay": "argenx", "kind": { "slug": "conference-presentation", "label": "Conference presentation" }, "sourceType": { "slug": "investor_relations", "label": "Investor relations" }, "fileName": "2023-07__argenx-se__results__08554301.pdf", "sourceUrl": "https://www.slidebook.io/company/argenx-se/presentation/085543019d5934281487d90fc26e88a2/", "sourceDate": "2023-07-27 00:00:00", "presentationDate": "2023-07-01 00:00:00", "ingestedAt": "2026-04-30 22:14:33.402812+00", "status": "ready", "pageCount": 15, "orientation": "landscape", "aspectRatio": 1.7777778, "targetCompany": null, "targetTicker": null, "metadata": { "corpus": "slidebook", "industry": "biotechnology", "local_root": "/Users/miguelsuredasuau/Desktop/lalalalla/_scrape/slidebook/decks/2023-07__argenx-se__results__08554301", "image_width": 1920, "image_format": "jpg", "deck_type_raw": "Results Presentation Deck", "deck_type_slug": null, "source_url_pattern": "https://www.slidebook.io/company/{company_slug}/presentation/{deck_id}/" } }, "coverage": { "pageCount": 15, "pagesIndexed": 15, "pagesWithImages": 15, "pagesWithMetadata": 15, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 73, "chartCount": 2, "metricSlides": 0, "toolMatches": 3, "documentToolMatches": 0, "frameworkMatches": 5, "arcMatches": 1, "beatMatches": 8, "loopMatches": 5, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": false, "reviewAvailable": false, "activistThesisAvailable": false, "pitchdeckMetadataAvailable": false, "pitchdeckProfileAvailable": false }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "evidence": "The presentation follows a 'why-how-what' structure, starting with the mission (why), then the strategy (how), and finally the results (what).", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 22:34:52.17338+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 3, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 3, "name": "Why", "beatId": "74736298-c289-40a8-aa54-f67833c03a44", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": { "name": "Why", "slug": "golden-circle-why", "status": "active", "canonId": "019dd9b8-1370-72ae-9655-1f7ce2ab6fe2", "version": 1, "description": null }, "evidence": "Our mission is to transform severe autoimmunity", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 4, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 4, "name": "Key Messages", "beatId": "4042a4ac-577c-44e4-b46e-0e8cd8bee312", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Driving Sustained Growth Across the Business", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 5, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 5, "name": "Problem", "beatId": "05492dc3-bfd3-470d-936c-bceffef47c97", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": { "name": "Problem (Identify pain)", "slug": "problem-agitate-solution-problem-identify-pain", "status": "active", "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131", "version": 1, "description": null }, "evidence": "ADHERE: Opportunity to Transform CIDP Patient Experience", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 6, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 6, "name": "Roadmap", "beatId": "e5d868bb-c506-47e5-9a5e-b29673084011", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Empasiprubart: Opportunity Across Multiple Autoimmune Diseases", "position": 3, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 8, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 8, "name": "KPIs", "beatId": "2f734848-fe4a-4326-85c7-7c02941ec394", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Second Quarter 2023 Finance Summary", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 9, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 9, "name": "Roadmap", "beatId": "b54d724a-8f41-4c49-9bc3-48af2bd5d477", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Multi-dimensional Expansion to Reach Autoimmune Patients Globally", "position": 5, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 11, "name": "Key Messages", "beatId": "74fbf466-b91f-4652-ac49-e35b08e26f8a", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "VYVGART Simplifies Treatment for Autoimmune Diseases", "position": 6, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 14, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null, "categoryName": "Narrative & Transformation", "categorySlug": "narrative-transformation" }, "from": 14, "name": "Key Takeaways", "beatId": "089a9db0-b394-4447-ad13-a45a78b7e68a", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Delivering on the Promise of Continuous Value Creation", "position": 7, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 3, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null, "categoryName": "Vision", "categorySlug": "vision" }, "matchId": "627b70f9-6545-44ba-bd44-65abf965472d", "evidence": "The presentation starts with the company's mission", "position": 0, "objective": "Understand the company's mission and purpose", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:34:52.565561+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 5, "from": 5, "loop": { "name": "21_before_after", "slug": "21-before-after", "status": "active", "bestFor": "Product demos, process improvements, ROI justification", "canonId": "019dd956-6e68-73fd-a295-fe90145c2da8", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison", "familyLabel": null, "categoryName": "Comparison", "categorySlug": "comparison" }, "matchId": "54f76381-9824-4185-9ad1-e421511382fa", "evidence": "The before-after comparison shows the opportunity to transform CIDP patient experience", "position": 1, "objective": "Highlight the benefits of ADHERE", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:34:52.608659+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 6, "from": 6, "loop": { "name": "36_maturity_curve", "slug": "36-maturity-curve", "status": "active", "bestFor": "Digital transformation, capability building, benchmarking", "canonId": "019dd956-748d-7329-ad3a-5c550b66e275", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Current Maturity Level -> The Gap to Next Level -> Required Capabilities -> The Roadmap", "description": "Show where you are on a progression and what it takes to reach the next level", "familyLabel": null, "categoryName": "Consulting Framework", "categorySlug": "consulting-framework" }, "matchId": "230fe403-8201-4db8-b7ec-38b6ac18620a", "evidence": "The roadmap shows the potential for empasiprubart across diseases", "position": 2, "objective": "Show the opportunity across multiple autoimmune diseases", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:34:52.651813+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 8, "from": 8, "loop": { "name": "50_pareto_focus", "slug": "50-pareto-focus", "status": "active", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "canonId": "019dd956-7a54-7637-bf68-bb63e3f018c7", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "description": "Show that 80% of results come from 20% of causes to drive prioritization", "familyLabel": null, "categoryName": "Consulting Framework", "categorySlug": "consulting-framework" }, "matchId": "200eef78-7315-464a-8d05-b0328f02313f", "evidence": "The second quarter 2023 finance summary provides key financial data", "position": 3, "objective": "Highlight key financial metrics", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:34:52.694672+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 14, "from": 14, "loop": { "name": "41_so_what_cascade", "slug": "41-so-what-cascade", "status": "active", "bestFor": "Data presentations, executive summaries, driving to recommendations", "canonId": "019dd956-769f-7208-afbc-f28985c6f4fb", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion", "familyLabel": null, "categoryName": "Consulting Framework", "categorySlug": "consulting-framework" }, "matchId": "99e2a2b7-1876-4e0a-8bbd-5a411ee2a163", "evidence": "The key takeaways section highlights the company's commitment to delivering value", "position": 4, "objective": "Emphasize continuous value creation", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:34:52.740983+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "Slide recipe: Cover", "slug": "cover-slide", "status": "active", "bestFor": null, "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3", "version": 1, "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65", "description": "The first ten seconds. Build it deliberately.", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "97484dff-9a64-48c7-b1b6-a1f92aaa2bfe", "evidence": "title/headline: Together We Discover", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 00:27:00.884354+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Three Pillars", "slug": "three-pillars", "status": "active", "bestFor": null, "canonId": "019dd956-81ef-7455-a365-b234d95a6bbb", "version": 1, "bodyDocId": null, "description": "Three major supporting arguments that are MECE and address key concerns", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Architect", "layer": "slide", "agents": [ "Architect" ], "matchId": "6bd00f9c-bbcc-4233-bd4b-21ee82dc7685", "evidence": "diagram/process: Four-step iterative process: Reaching More Patients, Geographic Expansion, Pioneer FcRn Class of Medicines, Broaden Immunology Pipeline", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-17 00:26:56.113996+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Before-After-Bridge", "slug": "before-after-bridge", "status": "active", "bestFor": null, "canonId": "019dd956-8604-7188-883f-42370288ad05", "version": 1, "bodyDocId": null, "description": "Narrative structure: Paint the before, show the after, explain the bridge", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "086d08c6-1d6d-4280-bb66-385b7f4f5bce", "evidence": "title/headline: ADHERE: Opportunity to Transform CIDP Patient Experience", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:26:56.1847+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "ec68dd24-d724-4fd3-8d7f-eff469db0ef1", "evidence": "The circular arrows connecting the four strategic pillars suggest a self-reinforcing growth cycle.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "flywheel" }, { "matchId": "aea2818f-359e-4378-8964-17a9b0c0d20e", "evidence": "Visual representation of strategic growth vectors over time/scale", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 11:46:06.828+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 9, "frameworkName": "roadmap" }, { "matchId": "f73889e8-7ab1-4e97-8851-decd9d83f34b", "evidence": "Geographic distribution of regulatory approvals", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 11:46:06.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 12, "frameworkName": "map-spatial" }, { "matchId": "6d2181fc-4d24-4bed-b02c-995e59381199", "evidence": "The slide uses a horizontal flow to connect strategic pillars to specific execution milestones.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 11:46:07.454+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 14, "frameworkName": "process" }, { "matchId": "65412262-51e4-4e93-8982-8e5f43ee1f40", "evidence": "Circular diagram with central logo and radiating value segments", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 11:46:06.899+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 15, "frameworkName": "hub-spoke" } ], "patterns": [] }, "storymakers": null, "score": null, "review": null, "activistThesis": null, "pitchdeck": { "metadata": null, "profile": null }, "slides": [ { "page": 1, "type": "setup", "function": "front_matter", "imagePath": "https://imgproxy.kitesheet.com/zhrApyfn9pZpJREgu9tGg4gph1vPfP9KXxEB7uTFv-4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wODU1NDMwMTlkNTkzNDI4MTQ4N2Q5MGZjMjZlODhhMi9wMDAxLmpwZw", "rawType": "cover", "block": null, "metadata": { "slideType": "cover", "slideTypeCanon": { "name": "Cover", "slug": "cover", "status": "active", "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410", "version": 1, "description": null }, "function": "front_matter", "functionCanon": { "name": "Front matter", "slug": "front_matter", "status": "active", "canonId": "019de52d-133d-73f0-9e26-201eda96b098", "version": 1, "description": null }, "density": "balanced", "densityScore": 34, "componentCount": 5, "textChars": 106, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.407+00", "seconds": 2.968, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/1", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-1", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.1, "w": 0.2, "x": 0.06, "y": 0.06 }, "kind": "image", "text": "argenx", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.407+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5c82e81c-f247-486b-9c58-e1fb3ab6d24d", "parentComponentId": null }, { "bbox": { "h": 1, "w": 0.5, "x": 0.5, "y": 0 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Photo", "slug": "photo", "status": "active", "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875", "version": 1, "description": null }, "framework": null }, "subkind": "photo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.407+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5e423f60-d0be-473e-83bf-302662d39949", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.55, "x": 0.06, "y": 0.8 }, "kind": "paragraph", "text": "Half Year 2023 Financial Results and Second Quarter Business Update", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.407+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0c514cc8-7fb3-430f-9292-2d4a979f8572", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.15, "x": 0.06, "y": 0.89 }, "kind": "paragraph", "text": "July 27, 2023", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.407+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b593f778-8b8c-4416-bfb7-80b87d5e4717", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.45, "x": 0.06, "y": 0.24 }, "kind": "title", "text": "Together We Discover", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.407+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "808fa997-3d2c-4b1a-9ee3-54c8e4400e80", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Slide recipe: Cover", "slug": "cover-slide", "status": "active", "bestFor": null, "canonId": "019df269-2a08-767d-9128-e7431e6fe8a3", "version": 1, "bodyDocId": "019df269-29e5-7738-b5fa-6892e5dc8e65", "description": "The first ten seconds. Build it deliberately.", "familyLabel": "slide-recipe", "categoryName": "Slide", "categorySlug": "slide" }, "agent": "designer", "layer": "slide", "agents": [ "designer" ], "matchId": "97484dff-9a64-48c7-b1b6-a1f92aaa2bfe", "evidence": "title/headline: Together We Discover", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.9, "extraction": { "at": "2026-07-17 00:27:00.884354+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/l6uYpY6Sr5CpacBlKPag7U5Bh07Z2gw8XDkBuqEV5WE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wODU1NDMwMTlkNTkzNDI4MTQ4N2Q5MGZjMjZlODhhMi9wMDAxLmpwZw", "imagePathAlt": "https://imgproxy.kitesheet.com/D4l7CX9HKvmqCj_AtmW5c1PGBL62skop44QAt-vXRHI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wODU1NDMwMTlkNTkzNDI4MTQ4N2Q5MGZjMjZlODhhMi9wMDAxLnBuZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/lSoJdRK7gJc7FdEt1EIMpEqzP_cHglwU9Ok2dPYOu10/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8wODU1NDMwMTlkNTkzNDI4MTQ4N2Q5MGZjMjZlODhhMi9wMDAxLnBuZw" }, { "page": 2, "type": "setup", "function": "other", "rawType": "disclaimer", "block": null, "metadata": { "slideType": "disclaimer", "slideTypeCanon": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "019de52d-0801-727b-b98a-5ed095aeee78", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "sparse", "densityScore": 12, "componentCount": 2, "textChars": 159, "nDataPoints": 0, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:05.448+00", "seconds": 1.893, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/2", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-2", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.6, "w": 0.9, "x": 0.05, "y": 0.25 }, "kind": "disclaimer", "text": "This presentation has been prepared by argenx... [legal text regarding forward-looking statements, third-party data, and SEC filings]", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:05.448+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "22a17410-f005-4d84-865a-537584ca500e", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.05, "y": 0.15 }, "kind": "title", "text": "Forward Looking Statements", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:05.448+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e04a51a2-dfca-415a-94ea-67c0a56d1a01", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 3, "type": "setup", "title": "The slide uses a corporate branding background with a network/molecular overlay.", "function": "establish_context", "rawType": "thesis_headline", "block": null, "metadata": { "slideType": "thesis_headline", "slideTypeCanon": { "name": "Thesis headline", "slug": "thesis_headline", "status": "active", "canonId": "019de52d-073a-70cb-b9f6-772a597bb5af", "version": 1, "description": null }, "function": "establish_context", "functionCanon": { "name": "Establish context", "slug": "establish_context", "status": "active", "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf", "version": 1, "description": null }, "density": "balanced", "densityScore": 27, "componentCount": 4, "textChars": 165, "nDataPoints": 0, "notes": "The slide uses a corporate branding background with a network/molecular overlay.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.434+00", "seconds": 2.766, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/3", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-3", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.06, "w": 0.14, "x": 0.83, "y": 0.05 }, "kind": "image", "text": "argenx", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.434+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "96105008-4964-49bf-818b-ffb651673612", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.35, "x": 0.1, "y": 0.65 }, "kind": "paragraph", "text": "Redefining autoimmune diseases as IgG-mediated", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.434+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e6dd365e-eb64-4af5-bb6e-598c432efdea", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.35, "x": 0.55, "y": 0.65 }, "kind": "paragraph", "text": "Raising expectations for what ‘well-controlled’ means for patients", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.434+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ff647b2a-671f-4f30-817e-8c0c29370f97", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.9, "x": 0.05, "y": 0.25 }, "kind": "title", "text": "Our mission is to transform severe autoimmunity", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.434+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7e959157-1c2c-4193-a5e9-d51478c9cee7", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 3, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 3, "name": "Why", "beatId": "74736298-c289-40a8-aa54-f67833c03a44", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": { "name": "Why", "slug": "golden-circle-why", "status": "active", "canonId": "019dd9b8-1370-72ae-9655-1f7ce2ab6fe2", "version": 1, "description": null }, "evidence": "Our mission is to transform severe autoimmunity", "position": 0, "isPrimaryArc": true, "parentBeatType": { "name": "Setup", "slug": "setup", "status": "active", "canonId": "019dd9b8-020e-7505-af9b-d9b9a4679bcc", "version": 1, "description": "Where the deck grounds the reader before doing anything else. Almost every arc opens here." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 3, "from": 3, "loop": { "name": "11_golden_circle", "slug": "11-golden-circle", "status": "active", "bestFor": "Visionary leadership, brand positioning, mission statements", "canonId": "019dd956-6a50-7202-882d-505fcb9922ed", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Why (Belief) -> The How (Process) -> The What (Result)", "description": "Invert the typical pitch by starting with why you exist, rather than what you do", "familyLabel": null }, "matchId": "627b70f9-6545-44ba-bd44-65abf965472d", "evidence": "The presentation starts with the company's mission", "position": 0, "objective": "Understand the company's mission and purpose", "confidence": 0.8, "extraction": { "at": "2026-07-16 22:34:52.565561+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 4, "type": "setup", "title": "The slide uses a circular, iterative process diagram to represent the growth strategy.", "function": "present_framework", "rawType": "key_messages", "block": null, "metadata": { "slideType": "key_messages", "slideTypeCanon": { "name": "Key messages", "slug": "key_messages", "status": "active", "canonId": "019de52d-0712-703f-89f5-bda6688faf3f", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "sparse", "densityScore": 21, "componentCount": 3, "textChars": 219, "nDataPoints": 0, "notes": "The slide uses a circular, iterative process diagram to represent the growth strategy.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.747+00", "seconds": 3.01, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/4", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-4", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.5, "w": 0.9, "x": 0.05, "y": 0.35 }, "kind": "diagram", "text": "Four-step iterative process: Reaching More Patients, Geographic Expansion, Pioneer FcRn Class of Medicines, Broaden Immunology Pipeline", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "7eff64dd-1c8c-4d7f-8ff7-7f0e28c15173", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.62, "x": 0.19, "y": 0.24 }, "kind": "title", "text": "Consistent Execution + Serial Innovation", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "beb95a93-969d-44e6-9409-aeff954cc648", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.58, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "Driving Sustained Growth Across the Business", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2f27daf0-a203-49e4-bf5f-15df64528ea8", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Three Pillars", "slug": "three-pillars", "status": "active", "bestFor": null, "canonId": "019dd956-81ef-7455-a365-b234d95a6bbb", "version": 1, "bodyDocId": null, "description": "Three major supporting arguments that are MECE and address key concerns", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Architect", "layer": "slide", "agents": [ "Architect" ], "matchId": "6bd00f9c-bbcc-4233-bd4b-21ee82dc7685", "evidence": "diagram/process: Four-step iterative process: Reaching More Patients, Geographic Expansion, Pioneer FcRn Class of Medicines, Broaden Immunology Pipeline", "pageRefs": null, "priority": "Core", "whenToUse": null, "confidence": 0.8, "extraction": { "at": "2026-07-17 00:26:56.113996+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "ec68dd24-d724-4fd3-8d7f-eff469db0ef1", "evidence": "The circular arrows connecting the four strategic pillars suggest a self-reinforcing growth cycle.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "flywheel" } ], "arcBeats": [ { "to": 4, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 4, "name": "Key Messages", "beatId": "4042a4ac-577c-44e4-b46e-0e8cd8bee312", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Driving Sustained Growth Across the Business", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 5, "type": "evidence", "title": "Kaplan-Meier survival curve showing probability of no relapse over 48 weeks.", "function": "analyze_data", "rawType": "before_after", "block": null, "metadata": { "slideType": "before_after", "slideTypeCanon": { "name": "Before / after", "slug": "before_after", "status": "active", "canonId": "019de52d-11fd-771e-bb45-e27f849bc560", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "dense", "densityScore": 64, "componentCount": 6, "textChars": 345, "nDataPoints": 12, "notes": "Kaplan-Meier survival curve showing probability of no relapse over 48 weeks.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.747+00", "seconds": 2.915, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/5", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-5", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.65, "w": 0.55, "x": 0.43, "y": 0.2 }, "kind": "chart", "text": "Kaplan-Meier curve of probability of no relapse", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Line chart", "slug": "line", "status": "active", "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677", "version": 1, "description": null }, "framework": null }, "subkind": "line", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4b406ea4-ab76-42a3-badc-6b04673a359c", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.2, "x": 0.15, "y": 0.58 }, "kind": "metric", "text": "HR: 0.39 P = 0.000039", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1e5a4827-866c-4674-9cb7-f94eaf4be60a", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.2, "x": 0.15, "y": 0.28 }, "kind": "metric", "text": "67% - 78%", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4e63c84d-6996-4dcd-ae3c-e5385a41f34d", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.35, "x": 0.05, "y": 0.7 }, "kind": "paragraph", "text": "61% lower risk of relapse based on time to first adjusted INCAT deterioration with VYVGART Hytrulo compared to placebo", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "74cc377d-26fa-4d91-a5e9-28e390997f2a", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.35, "x": 0.05, "y": 0.37 }, "kind": "paragraph", "text": "Response rates demonstrate IgG autoantibodies play significant role in underlying CIDP biology", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a71bfe98-eb86-488e-9784-e761eb706f1a", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.7, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "ADHERE: Opportunity to Transform CIDP Patient Experience", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.747+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "34185c3e-0cf6-4487-a5aa-c6476c9bd8ad", "parentComponentId": null } ], "metrics": [], "tools": [ { "tool": { "name": "Before-After-Bridge", "slug": "before-after-bridge", "status": "active", "bestFor": null, "canonId": "019dd956-8604-7188-883f-42370288ad05", "version": 1, "bodyDocId": null, "description": "Narrative structure: Paint the before, show the after, explain the bridge", "familyLabel": null, "categoryName": "Block", "categorySlug": "block" }, "agent": "Storyteller", "layer": "slide", "agents": [ "Storyteller" ], "matchId": "086d08c6-1d6d-4280-bb66-385b7f4f5bce", "evidence": "title/headline: ADHERE: Opportunity to Transform CIDP Patient Experience", "pageRefs": null, "priority": null, "whenToUse": null, "confidence": 0.7, "extraction": { "at": "2026-07-17 00:26:56.1847+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 5, "whyItWorks": null, "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [], "arcBeats": [ { "to": 5, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 5, "name": "Problem", "beatId": "05492dc3-bfd3-470d-936c-bceffef47c97", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": { "name": "Problem (Identify pain)", "slug": "problem-agitate-solution-problem-identify-pain", "status": "active", "canonId": "019dd9b8-0e78-74bb-b8f6-54348367a131", "version": 1, "description": null }, "evidence": "ADHERE: Opportunity to Transform CIDP Patient Experience", "position": 2, "isPrimaryArc": true, "parentBeatType": { "name": "Complication", "slug": "complication", "status": "active", "canonId": "019dd9b8-0275-7709-b2d6-4f77c3fc7579", "version": 1, "description": "The point in the narrative where the audience should feel discomfort. Required for argumentative arcs." }, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 5, "from": 5, "loop": { "name": "21_before_after", "slug": "21-before-after", "status": "active", "bestFor": "Product demos, process improvements, ROI justification", "canonId": "019dd956-6e68-73fd-a295-fe90145c2da8", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta", "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison", "familyLabel": null }, "matchId": "54f76381-9824-4185-9ad1-e421511382fa", "evidence": "The before-after comparison shows the opportunity to transform CIDP patient experience", "position": 1, "objective": "Highlight the benefits of ADHERE", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:34:52.608659+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 6, "type": "resolution", "title": "The slide uses a split-screen layout to contrast established proof-of-concept (left) with future development plans (right).", "function": "plan_implementation", "rawType": "roadmap", "block": null, "metadata": { "slideType": "roadmap", "slideTypeCanon": { "name": "Roadmap", "slug": "roadmap", "status": "active", "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c", "version": 1, "description": null }, "function": "plan_implementation", "functionCanon": { "name": "Plan implementation", "slug": "plan_implementation", "status": "active", "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823", "version": 1, "description": null }, "density": "balanced", "densityScore": 48, "componentCount": 5, "textChars": 330, "nDataPoints": 0, "notes": "The slide uses a split-screen layout to contrast established proof-of-concept (left) with future development plans (right).", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:07.411+00", "seconds": 3.532, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/6", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-6", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.25, "w": 0.4, "x": 0.55, "y": 0.55 }, "kind": "callout", "text": "On track to start proof-of-concept studies: Dermatomyositis, Delayed Graft Function in Kidney Transplant", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.411+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e17d1044-6023-4870-ab3e-7f900c934343", "parentComponentId": null }, { "bbox": { "h": 0.45, "w": 0.38, "x": 0.07, "y": 0.35 }, "kind": "image", "text": "Antibody diagram showing sweeping mechanism", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Illustration", "slug": "illustration", "status": "active", "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615", "version": 1, "description": null }, "framework": null }, "subkind": "illustration", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.411+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9002613e-9c50-4203-8c60-b48d10137387", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.4, "x": 0.55, "y": 0.33 }, "kind": "list", "text": "Enrolling second cohort; Topline ARDA results expected from both cohorts in 2024", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.411+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "10659833-a768-456a-93b8-7b9ff8964689", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.4, "x": 0.07, "y": 0.88 }, "kind": "source-note", "text": "Favorable safety and tolerability profile", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.411+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "104e5d61-d80e-40e2-9c63-5a7a997e0fd9", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.8, "x": 0.03, "y": 0.04 }, "kind": "title", "text": "Empasiprubart: Opportunity Across Multiple Autoimmune Diseases", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.411+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1d51ebd6-9e36-4295-b255-2355a9a6c731", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 6, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 6, "name": "Roadmap", "beatId": "e5d868bb-c506-47e5-9a5e-b29673084011", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Empasiprubart: Opportunity Across Multiple Autoimmune Diseases", "position": 3, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 6, "from": 6, "loop": { "name": "36_maturity_curve", "slug": "36-maturity-curve", "status": "active", "bestFor": "Digital transformation, capability building, benchmarking", "canonId": "019dd956-748d-7329-ad3a-5c550b66e275", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Current Maturity Level -> The Gap to Next Level -> Required Capabilities -> The Roadmap", "description": "Show where you are on a progression and what it takes to reach the next level", "familyLabel": null }, "matchId": "230fe403-8201-4db8-b7ec-38b6ac18620a", "evidence": "The roadmap shows the potential for empasiprubart across diseases", "position": 2, "objective": "Show the opportunity across multiple autoimmune diseases", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:34:52.651813+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 7, "type": "appendix", "title": "The slide uses a bubble-based layout to display various brand and study logos centered around the main argenx corporate logo.", "function": "establish_context", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "establish_context", "functionCanon": { "name": "Establish context", "slug": "establish_context", "status": "active", "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf", "version": 1, "description": null }, "density": "sparse", "densityScore": 16, "componentCount": 3, "textChars": 143, "nDataPoints": 0, "notes": "The slide uses a bubble-based layout to display various brand and study logos centered around the main argenx corporate logo.", "elementsJson": null, "confidence": 0.9, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.056+00", "seconds": 2.171, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/7", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-7", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.15, "w": 0.25, "x": 0.7, "y": 0.45 }, "kind": "image", "text": "argenx corporate logo", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo", "slug": "logo", "status": "active", "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302", "version": 1, "description": null }, "framework": null }, "subkind": "logo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.056+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "70a806a8-01e8-43b6-8613-89f87cc6f34f", "parentComponentId": null }, { "bbox": { "h": 0.55, "w": 0.98, "x": 0.01, "y": 0.33 }, "kind": "image", "text": "Collection of logos including alkivia, adapt, VYVGART, ARGX-119, adhere, and arda.", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Logo grid", "slug": "logo-grid", "status": "active", "canonId": "019de52c-fdd7-7409-93e5-81280a8ca215", "version": 1, "description": null }, "framework": null }, "subkind": "logo-grid", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.056+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "386cd705-a378-443a-8281-360e69fe2502", "parentComponentId": null }, { "bbox": { "h": 0.038, "w": 0.415, "x": 0.033, "y": 0.064 }, "kind": "title", "text": "Building Leadership Within Neuromuscular", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.056+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8aaa4e60-aeca-4cda-8ec7-7520bc7becfc", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 8, "type": "analysis", "title": "Includes a callout for cash position at end of Q2 2023.", "function": "analyze_data", "rawType": "kpi_overview", "block": null, "metadata": { "slideType": "kpi_overview", "slideTypeCanon": { "name": "KPI overview (contrarian)", "slug": "kpi_overview", "status": "active", "canonId": "019de52d-11d5-7328-b1d1-5368a03e7796", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 80, "componentCount": 7, "textChars": 537, "nDataPoints": 48, "notes": "Includes a callout for cash position at end of Q2 2023.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.774+00", "seconds": 2.882, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/8", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-8", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.12, "w": 0.47, "x": 0.5, "y": 0.74 }, "kind": "callout", "text": "Ended second quarter 2023 with cash of $2B", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.774+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0db53050-e01c-4699-b53f-8e99e1fac522", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.45, "x": 0.03, "y": 0.165 }, "kind": "chart", "text": "Q2 2023 Product Net Sales of $269M", "attrs": null, "canon": { "kind": { "name": "Chart", "slug": "chart", "status": "active", "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8", "version": 1, "description": "Quantitative chart." }, "tool": null, "subkind": { "name": "Vertical bar chart", "slug": "bar-vertical", "status": "active", "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917", "version": 1, "description": null }, "framework": null }, "subkind": "bar-vertical", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.774+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "56f66af8-5ed4-4804-a8d0-6dba56829224", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.45, "x": 0.03, "y": 0.925 }, "kind": "disclaimer", "text": "*QoQ growth % reflects operational growth, excluding any impact from changes in fx.", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.774+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "8b0a7242-546d-4d4e-b8fd-10fb83ab02d9", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.47, "x": 0.5, "y": 0.91 }, "kind": "disclaimer", "text": "Total Operating Expenses include Cost of Sales, R&D, SG&A and Loss from investment in joint venture. Financial income / (expenses) includes financial income / (expenses) and exchange gains / (losses). Cash reflects cash, cash equivalents and current financial assets. Table in $'m and impacted by rounding", "attrs": null, "canon": { "kind": { "name": "Disclaimer", "slug": "disclaimer", "status": "active", "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc", "version": 1, "description": "Legal/cautionary text that occupies most of the body of its slide." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.774+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "af01be77-f562-48df-aec4-b3f6e775adfb", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.45, "x": 0.03, "y": 0.545 }, "kind": "table", "text": "Product Net Sales by Region", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.774+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "57620228-c652-4a41-b8bd-52bfa211e3bb", "parentComponentId": null }, { "bbox": { "h": 0.55, "w": 0.47, "x": 0.5, "y": 0.165 }, "kind": "table", "text": "Summary P/L", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.774+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c53430fd-0bac-491d-85ae-d9f8a5b99075", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.45, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "Second Quarter 2023 Finance Summary", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.774+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "54034931-dc78-4446-9b31-7d4ca4aefa6e", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 8, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 8, "name": "KPIs", "beatId": "2f734848-fe4a-4326-85c7-7c02941ec394", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Second Quarter 2023 Finance Summary", "position": 4, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 8, "from": 8, "loop": { "name": "50_pareto_focus", "slug": "50-pareto-focus", "status": "active", "bestFor": "Resource allocation, problem prioritization, efficiency improvements", "canonId": "019dd956-7a54-7637-bf68-bb63e3f018c7", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Full Distribution -> The Vital Few (20%) -> The Trivial Many (80%) -> Focus Recommendation", "description": "Show that 80% of results come from 20% of causes to drive prioritization", "familyLabel": null }, "matchId": "200eef78-7315-464a-8d05-b0328f02313f", "evidence": "The second quarter 2023 finance summary provides key financial data", "position": 3, "objective": "Highlight key financial metrics", "confidence": 0.6, "extraction": { "at": "2026-07-16 22:34:52.694672+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 9, "type": "resolution", "title": "The slide uses a 3D-like coordinate system to represent growth vectors.", "function": "plan_implementation", "rawType": "roadmap", "block": null, "metadata": { "slideType": "roadmap", "slideTypeCanon": { "name": "Roadmap", "slug": "roadmap", "status": "active", "canonId": "019de52d-0a55-72bc-9b7b-a47ef109839c", "version": 1, "description": null }, "function": "plan_implementation", "functionCanon": { "name": "Plan implementation", "slug": "plan_implementation", "status": "active", "canonId": "019de52d-14a2-77ea-b210-d6a95eed4823", "version": 1, "description": null }, "density": "balanced", "densityScore": 48, "componentCount": 5, "textChars": 337, "nDataPoints": 0, "notes": "The slide uses a 3D-like coordinate system to represent growth vectors.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.828+00", "seconds": 2.89, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/9", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-9", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.8, "w": 0.85, "x": 0.1, "y": 0.12 }, "kind": "diagram", "text": "Growth vectors for Formulations, Indications, and Geographies", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.828+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f7973c83-325e-4e8e-a250-4c6e12a500ec", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.7, "x": 0.15, "y": 0.85 }, "kind": "list", "text": "Geographies: US, Japan, EMEA, UK, China, Future geographies", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.828+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ad73d248-65ca-4ab5-9f0c-9cf11ed636eb", "parentComponentId": null }, { "bbox": { "h": 0.6, "w": 0.6, "x": 0.25, "y": 0.15 }, "kind": "list", "text": "Indications: gMG, CIDP, ITP, Pemphigus, BP, Myositis, Future Indications", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.828+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b63fd90e-f8c7-4372-8350-5c5069380b57", "parentComponentId": null }, { "bbox": { "h": 0.5, "w": 0.2, "x": 0.01, "y": 0.25 }, "kind": "list", "text": "Formulations: VYVGART, VYVGART Hytrulo, Pre-Filled Syringe, Future presentations", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.828+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f0c51963-cf40-4f5d-aee6-14b6c7644373", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.9, "x": 0.08, "y": 0.04 }, "kind": "title", "text": "Multi-dimensional Expansion to Reach Autoimmune Patients Globally", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.828+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d9e26e65-c10d-43ee-8be0-babeb5f28bbb", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "aea2818f-359e-4378-8964-17a9b0c0d20e", "evidence": "Visual representation of strategic growth vectors over time/scale", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 11:46:06.828+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 9, "frameworkName": "roadmap" } ], "arcBeats": [ { "to": 9, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 9, "name": "Roadmap", "beatId": "b54d724a-8f41-4c49-9bc3-48af2bd5d477", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Multi-dimensional Expansion to Reach Autoimmune Patients Globally", "position": 5, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 10, "type": "analysis", "title": "The slide uses a central circular image overlaying key performance indicators.", "function": "analyze_data", "rawType": "kpi_overview", "block": null, "metadata": { "slideType": "kpi_overview", "slideTypeCanon": { "name": "KPI overview (contrarian)", "slug": "kpi_overview", "status": "active", "canonId": "019de52d-11d5-7328-b1d1-5368a03e7796", "version": 1, "description": null }, "function": "analyze_data", "functionCanon": { "name": "Analyze data", "slug": "analyze_data", "status": "active", "canonId": "019de52d-1590-7413-8c82-cc218cff40b4", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 77, "componentCount": 11, "textChars": 376, "nDataPoints": 3, "notes": "The slide uses a central circular image overlaying key performance indicators.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:08.655+00", "seconds": 4.686, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/10", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-10", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.7, "w": 0.3, "x": 0.35, "y": 0.15 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Photo", "slug": "photo", "status": "active", "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875", "version": 1, "description": null }, "framework": null }, "subkind": "photo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "73d065e8-2181-48cc-83b6-9e1ac29776d6", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.06, "y": 0.2 }, "kind": "list", "text": "VYVGART launched in US, Japan, Germany, Italy", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "13f086e3-18e3-464c-b861-69f13ee70c93", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.65, "y": 0.58 }, "kind": "list", "text": "Potential to drive earlier line uptake", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3659d9b7-40e3-4d54-a86e-0254c03ad5da", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.65, "y": 0.2 }, "kind": "list", "text": "Consistent prescriber growth to increase breadth of patients", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "42520d9d-c513-421f-9bb3-fa520f32e4b1", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.06, "y": 0.58 }, "kind": "list", "text": "17,000 addressable gMG patients", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4a82e891-0d1c-40ac-8c90-b1ba9a543623", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.06, "y": 0.75 }, "kind": "list", "text": "Consistent growth looking at month over month new patient starts", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "590f68c2-108f-4e6d-b53b-4556c6942cb4", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.65, "y": 0.75 }, "kind": "list", "text": "VYVGART Hytrulo launched in US", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e2f5fc08-660b-4a80-b432-da0cc3eea0d5", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.65, "y": 0.35 }, "kind": "metric", "text": ">2,100 PRESCRIBERS UNITED STATES", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "21e3fd2d-a5f6-47ef-a2eb-aa1fb07c63cc", "parentComponentId": null }, { "bbox": { "h": 0.1, "w": 0.3, "x": 0.06, "y": 0.35 }, "kind": "metric", "text": "10+ COUNTRIES", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2aa86f92-2bf7-4905-8dea-d7d2b171b8a7", "parentComponentId": null }, { "bbox": { "h": 0.3, "w": 0.3, "x": 0.35, "y": 0.35 }, "kind": "metric", "text": "$489M IN NET VYVGART SALES YTD", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": null, "subkind": { "name": "Big number", "slug": "big-number", "status": "active", "canonId": "019de52c-fc70-70c8-b965-0584548a9204", "version": 1, "description": null }, "framework": null }, "subkind": "big-number", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "affd35aa-7ea9-47f9-b4a5-8383390f0db0", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.4, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "Optimizing Core Launch Strategies", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:08.655+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "defe237e-18dc-4b96-9bf0-23c406704cb9", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 11, "type": "setup", "function": "present_solution", "rawType": "key_messages", "block": null, "metadata": { "slideType": "key_messages", "slideTypeCanon": { "name": "Key messages", "slug": "key_messages", "status": "active", "canonId": "019de52d-0712-703f-89f5-bda6688faf3f", "version": 1, "description": null }, "function": "present_solution", "functionCanon": { "name": "Present solution", "slug": "present_solution", "status": "active", "canonId": "019de52d-15b8-71da-bd23-2b767850cbce", "version": 1, "description": null }, "density": "dense", "densityScore": 69, "componentCount": 7, "textChars": 379, "nDataPoints": 1, "notes": null, "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:07.115+00", "seconds": 2.719, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/11", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-11", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.52, "w": 0.52, "x": 0.24, "y": 0.435 }, "kind": "image", "text": "Patient photo", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Photo", "slug": "photo", "status": "active", "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875", "version": 1, "description": null }, "framework": null }, "subkind": "photo", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.115+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6ee33c3b-7ebb-4cc9-bd1c-17744efc6b40", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.15, "x": 0.42, "y": 0.15 }, "kind": "list", "text": "Simple treatment initiation: broad access, no vaccination requirements", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.115+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6aad8900-8970-4181-8ef5-0fbb66550550", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.15, "x": 0.66, "y": 0.15 }, "kind": "list", "text": "Choice in HOW to be treated: IV infusion or SC injection", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.115+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "a0c27d1d-b3df-4c4e-9ed5-4e8d4303503a", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.15, "x": 0.83, "y": 0.5 }, "kind": "list", "text": "Options for site of care: infusion center, HCP office, etc.", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.115+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ba9e30f1-58d6-41a6-af65-63f97f20a206", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.17, "x": 0.04, "y": 0.5 }, "kind": "list", "text": "Demonstrated efficacy: 78% responders across first two", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.115+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d1e5579f-b7e5-4f55-9067-c8c9b494902d", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.15, "x": 0.18, "y": 0.15 }, "kind": "list", "text": "Predictable safety and tolerability: across many different dosing schedules", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.115+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ef106295-cbc1-47c3-9d2d-fecc0e4331a7", "parentComponentId": null }, { "bbox": { "h": 0.09, "w": 0.69, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "VYVGART Simplifies Treatment for Autoimmune Diseases", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.115+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "611ded09-ad1e-4c65-8916-5d222ff19d11", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 11, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 11, "name": "Key Messages", "beatId": "74fbf466-b91f-4652-ac49-e35b08e26f8a", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "VYVGART Simplifies Treatment for Autoimmune Diseases", "position": 6, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 12, "type": "setup", "title": "The slide uses a map to visualize geographic reach, paired with two tables detailing approval timelines for two different products.", "function": "establish_context", "rawType": "geographic_map", "block": null, "metadata": { "slideType": "geographic_map", "slideTypeCanon": { "name": "Geographic map", "slug": "geographic_map", "status": "active", "canonId": "019de52d-09de-7153-8845-584c1a9d0c83", "version": 1, "description": null }, "function": "establish_context", "functionCanon": { "name": "Establish context", "slug": "establish_context", "status": "active", "canonId": "019de52d-1314-74e6-9074-d213dc0bdcdf", "version": 1, "description": null }, "density": "balanced", "densityScore": 43, "componentCount": 4, "textChars": 296, "nDataPoints": 16, "notes": "The slide uses a map to visualize geographic reach, paired with two tables detailing approval timelines for two different products.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.952+00", "seconds": 2.511, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/12", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-12", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.75, "w": 0.6, "x": 0.03, "y": 0.15 }, "kind": "image", "text": null, "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Map", "slug": "map", "status": "active", "canonId": "019de52c-fe4d-77bd-b0a4-d72d58b9e5a4", "version": 1, "description": null }, "framework": null }, "subkind": "map", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "41630b3d-8fac-4ee6-8f09-f795ed446b86", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.3, "x": 0.665, "y": 0.18 }, "kind": "table", "text": "VYVGART Approvals: U.S. (DEC 2021), JAPAN (JAN 2022), EUROPE (SEPT 2022), UK (MAR 2023), ISRAEL (APRIL 2023), CHINA (JUNE 2023); Pending: CANADA (Q3 2023)", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "2042b281-b134-42fb-b566-b26362d8ee21", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.3, "x": 0.665, "y": 0.58 }, "kind": "table", "text": "VYVGART Hytrulo Approvals: U.S. (JUNE 2023); Pending: JAPAN (BY Q1 2024), EUROPE (Q4 2023), CHINA (2024)", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b18458ae-c3ba-4e27-95be-0e578c3c6885", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.45, "x": 0.035, "y": 0.05 }, "kind": "title", "text": "Reaching gMG Patients Across the Globe", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "924fd760-2f33-4405-ac54-5025caf1752b", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "f73889e8-7ab1-4e97-8851-decd9d83f34b", "evidence": "Geographic distribution of regulatory approvals", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 11:46:06.952+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 12, "frameworkName": "map-spatial" } ], "arcBeats": [], "loops": [], "locked": true }, { "page": 13, "type": "evidence", "title": "The slide uses a patient story to humanize the clinical goals of minimizing burden and achieving sustained responses.", "function": "illustrate_case", "rawType": "testimonial", "block": null, "metadata": { "slideType": "testimonial", "slideTypeCanon": { "name": "Testimonial", "slug": "testimonial", "status": "active", "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97", "version": 1, "description": null }, "function": "illustrate_case", "functionCanon": { "name": "Illustrate case", "slug": "illustrate_case", "status": "active", "canonId": "019de52d-13b4-772c-bb73-1873612a7463", "version": 1, "description": null }, "density": "dense", "densityScore": 52, "componentCount": 5, "textChars": 413, "nDataPoints": 0, "notes": "The slide uses a patient story to humanize the clinical goals of minimizing burden and achieving sustained responses.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:07.261+00", "seconds": 2.781, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/13", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-13", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.15, "w": 0.45, "x": 0.04, "y": 0.23 }, "kind": "callout", "text": "We want to transform treatment for patients", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.261+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "448cd15d-cae9-4d9b-b7de-c72966db1016", "parentComponentId": null }, { "bbox": { "h": 0.65, "w": 0.3, "x": 0.64, "y": 0.08 }, "kind": "image", "text": "Crystal, Living With CIDP", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Headshot", "slug": "headshot", "status": "active", "canonId": "019de52c-fd5f-765c-9282-38b54f61bbbf", "version": 1, "description": null }, "framework": null }, "subkind": "headshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.261+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d23fb489-cd45-4796-8cbb-91304c17efe6", "parentComponentId": null }, { "bbox": { "h": 0.35, "w": 0.45, "x": 0.06, "y": 0.48 }, "kind": "list", "text": "Minimize treatment burden\nAchieve broad and sustained responses\nRegain control of their lives, including professionally and socially", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.261+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "95e5c6c4-6fcd-4d90-a37a-1e24b0a2d6eb", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.3, "x": 0.64, "y": 0.74 }, "kind": "quote", "text": "I was the type of woman that would run first thing in the morning before work, and then CIDP hit, and it was like hitting the wall at a hundred miles an hour.", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": null, "subkind": { "name": "Testimonial", "slug": "testimonial", "status": "active", "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8", "version": 1, "description": null }, "framework": null }, "subkind": "testimonial", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.261+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "da1d7105-8330-4e6e-a299-0fbe683836f4", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.45, "x": 0.04, "y": 0.06 }, "kind": "title", "text": "Redefining What 'Well-Controlled' Means for the Patient", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.261+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "55691fca-e0d0-4a33-91ea-d299b874c63c", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 14, "type": "resolution", "title": "The slide uses a process-oriented layout to show how strategic pillars are supported by specific operational achievements.", "function": "summarize", "rawType": "key_takeaways", "block": null, "metadata": { "slideType": "key_takeaways", "slideTypeCanon": { "name": "Key takeaways", "slug": "key_takeaways", "status": "active", "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d", "version": 1, "description": null }, "function": "summarize", "functionCanon": { "name": "Summarize", "slug": "summarize", "status": "active", "canonId": "019de52d-1541-704f-b86f-bf7b75056373", "version": 1, "description": null }, "density": "balanced", "densityScore": 45, "componentCount": 4, "textChars": 495, "nDataPoints": 0, "notes": "The slide uses a process-oriented layout to show how strategic pillars are supported by specific operational achievements.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:07.454+00", "seconds": 2.754, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/14", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-14", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.4, "w": 0.9, "x": 0.05, "y": 0.15 }, "kind": "diagram", "text": "CONSISTENT EXECUTION + SERIAL INNOVATION", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Process flow", "slug": "process", "status": "active", "canonId": "019de52d-039c-718f-ad3a-efe9c4b3c838", "version": 1, "description": null }, "framework": null }, "subkind": "process", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.454+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "544d4c22-5bb4-4e9c-9561-295b84d0b898", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.9, "x": 0.05, "y": 0.65 }, "kind": "list", "text": "FDA approved VYVGART Hytrulo; Shift into earlier lines of treatment; Israel + China IV approvals; Japan ITP Submission; Canada IV approval; EMEA + Japan SC approvals; Positive topline results in CIDP; Topline results in pemphigus and ITP; Empasiprubart POC in MMN; Topline results in MMN in 2024", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.454+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d693681c-4a75-48d4-83f5-800e99038c63", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.8, "x": 0.1, "y": 0.3 }, "kind": "list", "text": "Reaching More Patients; Geographic Expansion; Pioneer FcRn Class of Medicines; Broaden Immunology Pipeline", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.454+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "eb7e0801-13d7-4b58-8532-8be01cd9cb52", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.6, "x": 0.03, "y": 0.05 }, "kind": "title", "text": "Delivering on the Promise of Continuous Value Creation", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:07.454+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "31889776-2394-487d-b45d-ce6dc6b3752b", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "6d2181fc-4d24-4bed-b02c-995e59381199", "evidence": "The slide uses a horizontal flow to connect strategic pillars to specific execution milestones.", "framework": null, "confidence": 0.8, "extraction": { "at": "2026-05-02 11:46:07.454+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 14, "frameworkName": "process" } ], "arcBeats": [ { "to": 14, "arc": { "name": "The Golden Circle", "slug": "golden-circle", "status": "active", "bestFor": "Brand storytelling, mission-driven pitches", "canonId": "019dd956-60cc-762d-a1e7-bf9c7d3b7590", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "Why -> How -> What", "description": null, "familyLabel": null }, "from": 14, "name": "Key Takeaways", "beatId": "089a9db0-b394-4447-ad13-a45a78b7e68a", "matchId": "20f5b06c-0a1c-4ca5-8e4e-b227d4471536", "beatType": null, "evidence": "Delivering on the Promise of Continuous Value Creation", "position": 7, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 14, "from": 14, "loop": { "name": "41_so_what_cascade", "slug": "41-so-what-cascade", "status": "active", "bestFor": "Data presentations, executive summaries, driving to recommendations", "canonId": "019dd956-769f-7208-afbc-f28985c6f4fb", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Data -> So What? (Insight 1) -> So What? (Insight 2) -> So What? (The Action)", "description": "Chain insights together, each answering 'so what?' until you reach the actionable conclusion", "familyLabel": null }, "matchId": "99e2a2b7-1876-4e0a-8bbd-5a411ee2a163", "evidence": "The key takeaways section highlights the company's commitment to delivering value", "position": 4, "objective": "Emphasize continuous value creation", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:34:52.740983+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 15, "type": "setup", "title": "The diagram is a hub-and-spoke model representing corporate values.", "function": "present_framework", "rawType": "key_messages", "block": null, "metadata": { "slideType": "key_messages", "slideTypeCanon": { "name": "Key messages", "slug": "key_messages", "status": "active", "canonId": "019de52d-0712-703f-89f5-bda6688faf3f", "version": 1, "description": null }, "function": "present_framework", "functionCanon": { "name": "Present framework", "slug": "present_framework", "status": "active", "canonId": "019de52d-1403-7667-9100-d2ac6709f750", "version": 1, "description": null }, "density": "sparse", "densityScore": 6, "componentCount": 2, "textChars": 64, "nDataPoints": 0, "notes": "The diagram is a hub-and-spoke model representing corporate values.", "elementsJson": null, "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 11:46:06.899+00", "seconds": 2.12, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019de075-3e55-76ad-a6bd-1aa5a42e575f/15", "deck": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f", "deckAnchor": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f#slide-15", "deckJson": "/decks/019de075-3e55-76ad-a6bd-1aa5a42e575f.json" }, "components": [ { "bbox": { "h": 0.9, "w": 0.5, "x": 0.45, "y": 0.05 }, "kind": "diagram", "text": "Argenx core values hub-and-spoke diagram", "attrs": null, "canon": { "kind": { "name": "Diagram", "slug": "diagram", "status": "active", "canonId": "019de52c-f9f0-734a-81de-15382ff28c65", "version": 1, "description": "Schematic or relational diagram." }, "tool": null, "subkind": { "name": "Hub and spoke", "slug": "hub-spoke", "status": "active", "canonId": "019de52d-04db-73e6-81ca-a234f2f23fc1", "version": 1, "description": null }, "framework": null }, "subkind": "hub-spoke", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.899+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "35b8d1d2-3433-4f8a-9f50-9fb84c6b3059", "parentComponentId": null }, { "bbox": { "h": 0.2, "w": 0.38, "x": 0.05, "y": 0.38 }, "kind": "title", "text": "Our mission continues...", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 11:46:06.899+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0ac06be6-d5a8-470a-a0d2-0ddf45a4a623", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "65412262-51e4-4e93-8982-8e5f43ee1f40", "evidence": "Circular diagram with central logo and radiating value segments", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 11:46:06.899+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 15, "frameworkName": "hub-spoke" } ], "arcBeats": [], "loops": [], "locked": true } ], "arcBeats": [ { "from": 3, "to": 3, "label": "Why", "description": "Our mission is to transform severe autoimmunity" }, { "from": 4, "to": 4, "label": "Key Messages", "description": "Driving Sustained Growth Across the Business" }, { "from": 5, "to": 5, "label": "Problem", "description": "ADHERE: Opportunity to Transform CIDP Patient Experience" }, { "from": 6, "to": 6, "label": "Roadmap", "description": "Empasiprubart: Opportunity Across Multiple Autoimmune Diseases" }, { "from": 8, "to": 8, "label": "KPIs", "description": "Second Quarter 2023 Finance Summary" }, { "from": 9, "to": 9, "label": "Roadmap", "description": "Multi-dimensional Expansion to Reach Autoimmune Patients Globally" }, { "from": 11, "to": 11, "label": "Key Messages", "description": "VYVGART Simplifies Treatment for Autoimmune Diseases" }, { "from": 14, "to": 14, "label": "Key Takeaways", "description": "Delivering on the Promise of Continuous Value Creation" } ], "loops": [ { "from": 3, "to": 3, "label": "Golden Circle", "description": "Understand the company's mission and purpose" }, { "from": 5, "to": 5, "label": "Before After", "description": "Highlight the benefits of ADHERE" }, { "from": 6, "to": 6, "label": "Maturity Curve", "description": "Show the opportunity across multiple autoimmune diseases" }, { "from": 8, "to": 8, "label": "Pareto Focus", "description": "Highlight key financial metrics" }, { "from": 14, "to": 14, "label": "So What Cascade", "description": "Emphasize continuous value creation" } ] }